Investing.com - Financial Markets Worldwide
Get 40% Off
Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

U.S. administers nearly 252 million doses of COVID-19 vaccines - CDC

Published 05/06/2021, 05:16 PM
Updated 05/06/2021, 05:21 PM
© Reuters. FILE PHOTO: A health care worker fills a syringe with Moderna COVID-19 vaccine as California opens up vaccine eligibility to any residents 16 years and older during the outbreak of coronavirus disease (COVID-19) in Chula Vista, California, U.S., April 15,

(Reuters) - The United States has administered 251,973,752 doses of COVID-19 vaccines in the country as of Thursday morning and distributed 324,610,185 doses, the U.S. Centers for Disease Control and Prevention said on Thursday.

Those figures are up from the 249,566,820 vaccine doses the CDC said had gone into arms by Wednesday out of 321,549,335 doses delivered.

The agency said 149,462,265 people had received at least one dose while 108,926,627 people are fully vaccinated as of Thursday.

The CDC tally includes two-dose vaccines from Moderna (NASDAQ:MRNA) and Pfizer/BioNTech, as well as Johnson & Johnson (NYSE:JNJ)'s one-shot vaccine as of 6:00 a.m. ET on Thursday.

A total of 7,805,656 vaccine doses have been administered in long-term care facilities, the agency said.

Latest comments

Thanks to Bill Gates
And now cases are rising at all time highs, resistant strains at all time highs, and number of deaths and adverse events in the VAERS system higher in the past year due to COVID-19 vaccines than all other vaccine administrations of the past decade combined. Government and pharma companies milking the sheep all they can
And now cases are rising at all time highs, resistant strains at all time highs, and number of deaths and adverse events in the VAERS system higher in the past year due to COVID-19 vaccines than all other vaccine administrations of the past decade combined.
We can thank the Trump administration for Operation Warp Speed.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.